HIGHLIGHTS
- who: Hang Ouyang from the (UNIVERSITY) have published the paper: A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients, in the Journal: (JOURNAL)
- what: Compared with nondiabetic patients, DM patients have a higher risk of severe multivascular coronary blood flow disorders and worse prognosis.
SUMMARY
For DM patients, as reported by Conder in 2017, EES has significant advantages over other stents, including SES and PES, and therefore is recommended as the priority choice of DM patients undergoing PCI. The authors performed this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.